Malik Kahook
Concepts (441)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glaucoma | 57 | 2023 | 202 | 16.060 |
Why?
| Intraocular Pressure | 68 | 2023 | 275 | 10.470 |
Why?
| Glaucoma, Open-Angle | 27 | 2023 | 95 | 7.380 |
Why?
| Trabecular Meshwork | 23 | 2019 | 75 | 6.080 |
Why?
| Glaucoma Drainage Implants | 18 | 2022 | 47 | 5.660 |
Why?
| Antihypertensive Agents | 27 | 2019 | 437 | 5.260 |
Why?
| Trabeculectomy | 16 | 2022 | 65 | 4.520 |
Why?
| Angiogenesis Inhibitors | 15 | 2021 | 219 | 4.060 |
Why?
| Ocular Hypertension | 17 | 2022 | 60 | 3.920 |
Why?
| Filtering Surgery | 9 | 2016 | 22 | 3.620 |
Why?
| Conjunctiva | 13 | 2012 | 52 | 3.620 |
Why?
| Preservatives, Pharmaceutical | 11 | 2013 | 24 | 3.440 |
Why?
| Benzalkonium Compounds | 10 | 2012 | 14 | 2.780 |
Why?
| Tonometry, Ocular | 23 | 2021 | 83 | 2.760 |
Why?
| Vascular Endothelial Growth Factor A | 12 | 2021 | 527 | 2.650 |
Why?
| Ophthalmic Solutions | 17 | 2019 | 66 | 2.580 |
Why?
| Prostaglandins F, Synthetic | 8 | 2014 | 9 | 2.540 |
Why?
| Timolol | 8 | 2019 | 14 | 2.540 |
Why?
| Phacoemulsification | 12 | 2023 | 103 | 2.340 |
Why?
| Ciliary Body | 11 | 2018 | 33 | 2.130 |
Why?
| Glaucoma, Neovascular | 5 | 2015 | 10 | 1.950 |
Why?
| Cloprostenol | 9 | 2013 | 12 | 1.930 |
Why?
| Laser Coagulation | 9 | 2023 | 55 | 1.620 |
Why?
| Lens Implantation, Intraocular | 7 | 2020 | 60 | 1.570 |
Why?
| Antibodies, Monoclonal | 11 | 2011 | 1284 | 1.560 |
Why?
| Cataract Extraction | 6 | 2020 | 82 | 1.530 |
Why?
| Cataract | 8 | 2020 | 194 | 1.520 |
Why?
| Cornea | 8 | 2013 | 117 | 1.500 |
Why?
| Prosthesis Implantation | 8 | 2022 | 141 | 1.490 |
Why?
| Drug Delivery Systems | 7 | 2019 | 306 | 1.400 |
Why?
| Retinal Ganglion Cells | 5 | 2016 | 92 | 1.340 |
Why?
| Blister | 4 | 2012 | 39 | 1.340 |
Why?
| Stents | 5 | 2021 | 457 | 1.330 |
Why?
| Tomography, Optical Coherence | 6 | 2014 | 126 | 1.310 |
Why?
| Travoprost | 10 | 2014 | 12 | 1.270 |
Why?
| Medication Adherence | 5 | 2016 | 556 | 1.260 |
Why?
| Nerve Fibers | 4 | 2012 | 89 | 1.230 |
Why?
| Minimally Invasive Surgical Procedures | 3 | 2019 | 158 | 1.200 |
Why?
| Sulfonamides | 4 | 2018 | 445 | 1.200 |
Why?
| Optic Disk | 5 | 2023 | 36 | 1.170 |
Why?
| Humans | 126 | 2023 | 118974 | 1.160 |
Why?
| Glaucoma, Angle-Closure | 5 | 2018 | 16 | 1.140 |
Why?
| Lenses, Intraocular | 4 | 2020 | 45 | 1.100 |
Why?
| Lens, Crystalline | 2 | 2020 | 126 | 1.090 |
Why?
| Capsulorhexis | 2 | 2016 | 8 | 1.080 |
Why?
| Eye | 6 | 2013 | 106 | 1.040 |
Why?
| Macular Degeneration | 4 | 2010 | 151 | 1.040 |
Why?
| Polymers | 5 | 2011 | 482 | 1.020 |
Why?
| Microscopy | 4 | 2018 | 125 | 1.020 |
Why?
| Photons | 4 | 2016 | 55 | 1.010 |
Why?
| Receptors, Vascular Endothelial Growth Factor | 2 | 2015 | 103 | 0.960 |
Why?
| Optic Nerve Diseases | 2 | 2022 | 32 | 0.940 |
Why?
| Ophthalmologic Surgical Procedures | 4 | 2014 | 60 | 0.930 |
Why?
| Endoscopy | 7 | 2018 | 272 | 0.920 |
Why?
| Aged | 41 | 2021 | 19657 | 0.890 |
Why?
| Cell Survival | 8 | 2013 | 1047 | 0.880 |
Why?
| Antibodies, Monoclonal, Humanized | 12 | 2011 | 667 | 0.880 |
Why?
| Brimonidine Tartrate | 3 | 2018 | 9 | 0.860 |
Why?
| Bevacizumab | 12 | 2021 | 124 | 0.850 |
Why?
| Visual Acuity | 11 | 2022 | 272 | 0.840 |
Why?
| Drug Packaging | 4 | 2015 | 44 | 0.830 |
Why?
| Laser Therapy | 3 | 2016 | 104 | 0.800 |
Why?
| Recombinant Fusion Proteins | 2 | 2015 | 653 | 0.790 |
Why?
| Thiazines | 2 | 2018 | 9 | 0.770 |
Why?
| Prosthesis Design | 4 | 2016 | 285 | 0.770 |
Why?
| Epithelium, Corneal | 2 | 2010 | 40 | 0.750 |
Why?
| Spectrum Analysis, Raman | 4 | 2013 | 43 | 0.750 |
Why?
| Drug Combinations | 9 | 2017 | 291 | 0.740 |
Why?
| Thiophenes | 2 | 2011 | 106 | 0.730 |
Why?
| Sclera | 7 | 2015 | 36 | 0.730 |
Why?
| Vision Disorders | 3 | 2020 | 135 | 0.710 |
Why?
| Microscopy, Fluorescence, Multiphoton | 8 | 2016 | 66 | 0.700 |
Why?
| Middle Aged | 39 | 2020 | 27617 | 0.700 |
Why?
| beta-Alanine | 1 | 2019 | 20 | 0.680 |
Why?
| Benzoates | 1 | 2019 | 40 | 0.680 |
Why?
| Imaging, Three-Dimensional | 5 | 2016 | 499 | 0.670 |
Why?
| Aged, 80 and over | 20 | 2019 | 6561 | 0.670 |
Why?
| Pilocarpine | 1 | 2018 | 8 | 0.670 |
Why?
| rho-Associated Kinases | 1 | 2019 | 84 | 0.650 |
Why?
| Ranibizumab | 8 | 2021 | 18 | 0.640 |
Why?
| Male | 52 | 2021 | 57801 | 0.620 |
Why?
| Cells, Cultured | 12 | 2015 | 4077 | 0.620 |
Why?
| Ocular Hypotension | 4 | 2022 | 10 | 0.620 |
Why?
| Retinal Pigment Epithelium | 4 | 2015 | 60 | 0.610 |
Why?
| Prostaglandins F | 3 | 2011 | 18 | 0.600 |
Why?
| Treatment Outcome | 18 | 2022 | 9342 | 0.600 |
Why?
| Equipment Design | 6 | 2018 | 519 | 0.600 |
Why?
| Anterior Capsule of the Lens | 1 | 2016 | 2 | 0.590 |
Why?
| Prospective Studies | 14 | 2021 | 6471 | 0.590 |
Why?
| Epithelial Cells | 3 | 2011 | 963 | 0.580 |
Why?
| Ophthalmology | 4 | 2022 | 80 | 0.580 |
Why?
| Patient Compliance | 4 | 2018 | 537 | 0.580 |
Why?
| Female | 49 | 2022 | 61565 | 0.560 |
Why?
| Intravitreal Injections | 6 | 2021 | 46 | 0.550 |
Why?
| Circadian Rhythm | 3 | 2023 | 401 | 0.540 |
Why?
| Wound Healing | 3 | 2012 | 270 | 0.540 |
Why?
| Retrospective Studies | 24 | 2023 | 12978 | 0.540 |
Why?
| Diabetic Retinopathy | 2 | 2023 | 160 | 0.540 |
Why?
| Oxidative Stress | 2 | 2013 | 1178 | 0.530 |
Why?
| Uveitis | 3 | 2022 | 116 | 0.530 |
Why?
| Motivational Interviewing | 1 | 2016 | 84 | 0.530 |
Why?
| Mitomycin | 3 | 2016 | 27 | 0.520 |
Why?
| Reminder Systems | 1 | 2016 | 163 | 0.500 |
Why?
| Pharmaceutical Preparations | 2 | 2019 | 167 | 0.490 |
Why?
| Behavior Therapy | 1 | 2016 | 237 | 0.490 |
Why?
| Iris | 4 | 2013 | 19 | 0.480 |
Why?
| Patient Preference | 1 | 2016 | 170 | 0.480 |
Why?
| Injections | 6 | 2010 | 167 | 0.470 |
Why?
| Pyruvates | 1 | 2013 | 20 | 0.470 |
Why?
| Administration, Topical | 5 | 2016 | 141 | 0.460 |
Why?
| Cell Count | 4 | 2021 | 315 | 0.460 |
Why?
| Stainless Steel | 2 | 2010 | 21 | 0.460 |
Why?
| Pseudophakia | 2 | 2018 | 11 | 0.460 |
Why?
| Porphyrins | 1 | 2013 | 17 | 0.460 |
Why?
| Perception | 3 | 2021 | 314 | 0.450 |
Why?
| Anterior Chamber | 2 | 2012 | 21 | 0.450 |
Why?
| Triamcinolone Acetonide | 2 | 2014 | 24 | 0.450 |
Why?
| Photosensitizing Agents | 1 | 2013 | 28 | 0.450 |
Why?
| Goblet Cells | 2 | 2012 | 17 | 0.440 |
Why?
| Telemedicine | 1 | 2021 | 664 | 0.430 |
Why?
| Health Behavior | 2 | 2015 | 720 | 0.430 |
Why?
| Dose-Response Relationship, Drug | 6 | 2011 | 1945 | 0.420 |
Why?
| Follow-Up Studies | 10 | 2022 | 4596 | 0.420 |
Why?
| Rabbits | 7 | 2015 | 780 | 0.420 |
Why?
| Drugs, Generic | 1 | 2011 | 18 | 0.410 |
Why?
| Vitreous Body | 5 | 2010 | 104 | 0.400 |
Why?
| Drug Therapy | 1 | 2011 | 76 | 0.400 |
Why?
| Surgically-Created Structures | 1 | 2011 | 2 | 0.400 |
Why?
| NADP | 1 | 2011 | 50 | 0.390 |
Why?
| Adipocytes | 1 | 2012 | 199 | 0.390 |
Why?
| Fibrin Tissue Adhesive | 2 | 2010 | 13 | 0.380 |
Why?
| Tissue Adhesives | 2 | 2010 | 18 | 0.380 |
Why?
| Blood Pressure | 2 | 2017 | 1664 | 0.380 |
Why?
| Choroid | 1 | 2010 | 47 | 0.380 |
Why?
| Wet Macular Degeneration | 1 | 2010 | 32 | 0.370 |
Why?
| Endothelins | 1 | 2010 | 62 | 0.370 |
Why?
| Dexamethasone | 1 | 2012 | 320 | 0.360 |
Why?
| Prescription Drugs | 1 | 2011 | 113 | 0.360 |
Why?
| Adult | 19 | 2023 | 31512 | 0.350 |
Why?
| Quinoxalines | 1 | 2009 | 62 | 0.350 |
Why?
| Hydrogen Peroxide | 1 | 2011 | 305 | 0.350 |
Why?
| Particulate Matter | 2 | 2011 | 244 | 0.340 |
Why?
| Anxiety Disorders | 1 | 2012 | 309 | 0.340 |
Why?
| Depressive Disorder | 1 | 2012 | 333 | 0.340 |
Why?
| Anti-Infective Agents | 1 | 2011 | 227 | 0.330 |
Why?
| Diagnostic Techniques, Ophthalmological | 3 | 2020 | 36 | 0.330 |
Why?
| In Vitro Techniques | 4 | 2011 | 1094 | 0.330 |
Why?
| Primary Health Care | 2 | 2009 | 1560 | 0.330 |
Why?
| Surgical Wound Dehiscence | 1 | 2008 | 19 | 0.330 |
Why?
| Collagen | 5 | 2016 | 433 | 0.330 |
Why?
| Software | 1 | 2012 | 613 | 0.320 |
Why?
| Aqueous Humor | 4 | 2016 | 31 | 0.310 |
Why?
| Postoperative Complications | 7 | 2021 | 2235 | 0.310 |
Why?
| Cognition Disorders | 1 | 2012 | 529 | 0.310 |
Why?
| Neovascularization, Pathologic | 4 | 2013 | 287 | 0.300 |
Why?
| Retinoschisis | 1 | 2006 | 2 | 0.300 |
Why?
| Animals | 22 | 2016 | 33381 | 0.300 |
Why?
| Endothelium, Corneal | 2 | 2021 | 12 | 0.290 |
Why?
| Trypan Blue | 1 | 2006 | 4 | 0.290 |
Why?
| Reproducibility of Results | 7 | 2021 | 2874 | 0.290 |
Why?
| Fluorescence | 3 | 2011 | 159 | 0.290 |
Why?
| Self Administration | 1 | 2007 | 125 | 0.290 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 1185 | 0.280 |
Why?
| Coloring Agents | 1 | 2006 | 73 | 0.280 |
Why?
| Carbohydrate Metabolism, Inborn Errors | 1 | 2006 | 2 | 0.280 |
Why?
| Administration, Ophthalmic | 2 | 2019 | 14 | 0.280 |
Why?
| Optic Nerve | 1 | 2006 | 65 | 0.280 |
Why?
| Contact Lenses | 3 | 2020 | 8 | 0.270 |
Why?
| Eye Injuries | 2 | 2006 | 46 | 0.270 |
Why?
| Iridectomy | 1 | 2005 | 1 | 0.270 |
Why?
| Pseudotumor Cerebri | 1 | 2006 | 22 | 0.270 |
Why?
| Retinal Degeneration | 1 | 2006 | 31 | 0.270 |
Why?
| Acrylic Resins | 2 | 2016 | 39 | 0.270 |
Why?
| Monitoring, Physiologic | 2 | 2018 | 272 | 0.260 |
Why?
| Histological Techniques | 2 | 2018 | 43 | 0.260 |
Why?
| Pilot Projects | 5 | 2018 | 1419 | 0.260 |
Why?
| Glucocorticoids | 2 | 2016 | 545 | 0.260 |
Why?
| Visual Fields | 2 | 2020 | 78 | 0.250 |
Why?
| Cadaver | 3 | 2016 | 327 | 0.250 |
Why?
| Postoperative Period | 4 | 2019 | 309 | 0.250 |
Why?
| Alkylating Agents | 3 | 2016 | 25 | 0.240 |
Why?
| Surveys and Questionnaires | 6 | 2022 | 4708 | 0.240 |
Why?
| United States Food and Drug Administration | 2 | 2015 | 175 | 0.240 |
Why?
| Image Processing, Computer-Assisted | 3 | 2013 | 709 | 0.240 |
Why?
| Retina | 3 | 2016 | 278 | 0.230 |
Why?
| Drug Stability | 3 | 2011 | 153 | 0.220 |
Why?
| Prostaglandins, Synthetic | 2 | 2013 | 7 | 0.220 |
Why?
| Titanium | 2 | 2014 | 67 | 0.220 |
Why?
| Visual Field Tests | 1 | 2022 | 14 | 0.210 |
Why?
| Cross-Sectional Studies | 7 | 2022 | 4552 | 0.210 |
Why?
| Wounds, Nonpenetrating | 1 | 2005 | 285 | 0.210 |
Why?
| Self Report | 2 | 2016 | 699 | 0.210 |
Why?
| Heart Rate | 2 | 2017 | 729 | 0.200 |
Why?
| Drug Storage | 2 | 2011 | 59 | 0.200 |
Why?
| Case-Control Studies | 4 | 2016 | 3171 | 0.200 |
Why?
| Young Adult | 8 | 2019 | 10793 | 0.200 |
Why?
| Artificial Intelligence | 1 | 2022 | 140 | 0.190 |
Why?
| Eye Diseases | 2 | 2013 | 77 | 0.190 |
Why?
| Legislation, Drug | 1 | 2020 | 78 | 0.180 |
Why?
| Specialization | 1 | 2020 | 120 | 0.170 |
Why?
| Remote Sensing Technology | 1 | 2019 | 11 | 0.170 |
Why?
| Attitude | 1 | 2021 | 231 | 0.170 |
Why?
| Biosensing Techniques | 1 | 2020 | 107 | 0.170 |
Why?
| Magnetic Resonance Imaging | 1 | 2010 | 3174 | 0.170 |
Why?
| Limbus Corneae | 2 | 2015 | 4 | 0.170 |
Why?
| Medical Marijuana | 1 | 2020 | 102 | 0.160 |
Why?
| Fibroblasts | 2 | 2013 | 842 | 0.160 |
Why?
| Uveitis, Anterior | 1 | 2018 | 11 | 0.160 |
Why?
| Medication Errors | 2 | 2015 | 92 | 0.160 |
Why?
| Double-Blind Method | 2 | 2019 | 1687 | 0.150 |
Why?
| Marijuana Use | 1 | 2020 | 157 | 0.150 |
Why?
| Tropicamide | 1 | 2016 | 2 | 0.150 |
Why?
| Mydriatics | 1 | 2016 | 3 | 0.150 |
Why?
| Marijuana Smoking | 1 | 2020 | 220 | 0.150 |
Why?
| Phenylephrine | 1 | 2016 | 85 | 0.140 |
Why?
| Burnout, Professional | 1 | 2022 | 330 | 0.140 |
Why?
| Adrenergic beta-Antagonists | 1 | 2019 | 301 | 0.140 |
Why?
| Corneal Diseases | 1 | 2016 | 36 | 0.140 |
Why?
| Delayed-Action Preparations | 2 | 2018 | 161 | 0.140 |
Why?
| Endophthalmitis | 1 | 2016 | 25 | 0.140 |
Why?
| Fibrosis | 1 | 2018 | 483 | 0.140 |
Why?
| Coronary Artery Disease | 1 | 2022 | 647 | 0.130 |
Why?
| Artificial Lens Implant Migration | 1 | 2015 | 3 | 0.130 |
Why?
| Hyaluronic Acid | 2 | 2008 | 197 | 0.130 |
Why?
| Disease Management | 1 | 2019 | 571 | 0.130 |
Why?
| Endothelial Cells | 1 | 2021 | 732 | 0.130 |
Why?
| Swine | 3 | 2013 | 730 | 0.130 |
Why?
| Alloys | 1 | 2015 | 31 | 0.130 |
Why?
| Surgical Flaps | 1 | 2016 | 118 | 0.130 |
Why?
| Diabetes Mellitus | 1 | 2023 | 942 | 0.130 |
Why?
| Lasers, Semiconductor | 1 | 2015 | 11 | 0.130 |
Why?
| Combined Modality Therapy | 2 | 2010 | 1166 | 0.130 |
Why?
| Capsule Opacification | 1 | 2015 | 27 | 0.130 |
Why?
| Endpoint Determination | 1 | 2015 | 69 | 0.130 |
Why?
| Biodegradable Plastics | 1 | 2014 | 4 | 0.130 |
Why?
| Patient Acceptance of Health Care | 2 | 2018 | 687 | 0.130 |
Why?
| Micelles | 1 | 2014 | 34 | 0.130 |
Why?
| Referral and Consultation | 1 | 2019 | 648 | 0.120 |
Why?
| Viscosupplements | 1 | 2014 | 10 | 0.120 |
Why?
| Drug Therapy, Combination | 2 | 2018 | 965 | 0.120 |
Why?
| Societies, Medical | 2 | 2015 | 703 | 0.120 |
Why?
| Cell Proliferation | 2 | 2012 | 2275 | 0.120 |
Why?
| Autopsy | 2 | 2011 | 89 | 0.120 |
Why?
| Nickel | 1 | 2014 | 53 | 0.120 |
Why?
| Physicians | 1 | 2022 | 794 | 0.120 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 304 | 0.120 |
Why?
| Drug Synergism | 1 | 2014 | 339 | 0.120 |
Why?
| Gonioscopy | 1 | 2013 | 6 | 0.110 |
Why?
| Neuroprotective Agents | 1 | 2014 | 111 | 0.110 |
Why?
| Postoperative Care | 2 | 2012 | 237 | 0.110 |
Why?
| Tissue Scaffolds | 1 | 2015 | 184 | 0.110 |
Why?
| Protective Agents | 1 | 2013 | 42 | 0.110 |
Why?
| Models, Psychological | 1 | 2015 | 298 | 0.110 |
Why?
| Macular Edema | 2 | 2016 | 36 | 0.110 |
Why?
| Photochemotherapy | 1 | 2013 | 29 | 0.110 |
Why?
| Drug Monitoring | 1 | 2014 | 187 | 0.110 |
Why?
| Antimetabolites | 1 | 2012 | 25 | 0.110 |
Why?
| Cross-Over Studies | 1 | 2014 | 456 | 0.110 |
Why?
| Manifest Anxiety Scale | 1 | 2012 | 3 | 0.110 |
Why?
| Patient Satisfaction | 1 | 2016 | 610 | 0.110 |
Why?
| Pandemics | 1 | 2021 | 1355 | 0.110 |
Why?
| Melanins | 1 | 2011 | 22 | 0.100 |
Why?
| Diagnostic Imaging | 1 | 2014 | 294 | 0.100 |
Why?
| Drug Contamination | 1 | 2011 | 54 | 0.100 |
Why?
| Fluoresceins | 1 | 2011 | 47 | 0.100 |
Why?
| Needles | 1 | 2012 | 56 | 0.100 |
Why?
| Elastin | 1 | 2011 | 77 | 0.100 |
Why?
| Fluorescein-5-isothiocyanate | 1 | 2011 | 38 | 0.100 |
Why?
| Biocompatible Materials | 1 | 2015 | 378 | 0.100 |
Why?
| Psychometrics | 1 | 2015 | 631 | 0.100 |
Why?
| Self Efficacy | 1 | 2015 | 366 | 0.100 |
Why?
| Cell Death | 1 | 2013 | 339 | 0.100 |
Why?
| Cattle | 1 | 2014 | 978 | 0.100 |
Why?
| Mice, Inbred C57BL | 4 | 2016 | 4908 | 0.100 |
Why?
| Lasers | 1 | 2011 | 124 | 0.100 |
Why?
| Fovea Centralis | 1 | 2010 | 8 | 0.100 |
Why?
| Dextrans | 1 | 2011 | 74 | 0.100 |
Why?
| Silicone Oils | 1 | 2011 | 25 | 0.100 |
Why?
| Memory Disorders | 1 | 2012 | 168 | 0.100 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2011 | 127 | 0.100 |
Why?
| Anti-Inflammatory Agents | 1 | 2014 | 465 | 0.100 |
Why?
| Immunoglobulin Fragments | 1 | 2010 | 15 | 0.100 |
Why?
| Retreatment | 1 | 2010 | 71 | 0.100 |
Why?
| Physician-Patient Relations | 1 | 2015 | 490 | 0.100 |
Why?
| Electromagnetic Fields | 1 | 2010 | 21 | 0.100 |
Why?
| Motivation | 1 | 2015 | 506 | 0.090 |
Why?
| Equipment Safety | 1 | 2010 | 38 | 0.090 |
Why?
| Geriatric Assessment | 1 | 2012 | 185 | 0.090 |
Why?
| Microscopy, Electron, Scanning | 4 | 2015 | 196 | 0.090 |
Why?
| Immunoglobulin Light Chains | 1 | 2010 | 35 | 0.090 |
Why?
| Tissue Donors | 1 | 2012 | 336 | 0.090 |
Why?
| Chromatography, Gel | 1 | 2010 | 133 | 0.090 |
Why?
| Torque | 1 | 2010 | 67 | 0.090 |
Why?
| Immunoglobulin Heavy Chains | 1 | 2010 | 72 | 0.090 |
Why?
| Molecular Weight | 1 | 2010 | 343 | 0.090 |
Why?
| Protein Multimerization | 1 | 2011 | 161 | 0.090 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2011 | 490 | 0.090 |
Why?
| Aptamers, Nucleotide | 1 | 2010 | 74 | 0.090 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 332 | 0.090 |
Why?
| Microfluidic Analytical Techniques | 1 | 2010 | 75 | 0.090 |
Why?
| Endocrine System Diseases | 1 | 2009 | 32 | 0.090 |
Why?
| Communication | 1 | 2015 | 761 | 0.090 |
Why?
| Cell Separation | 1 | 2010 | 296 | 0.090 |
Why?
| Fluorescent Dyes | 1 | 2011 | 316 | 0.090 |
Why?
| Risk Assessment | 2 | 2020 | 3057 | 0.090 |
Why?
| Tandem Mass Spectrometry | 1 | 2011 | 421 | 0.090 |
Why?
| Reference Values | 1 | 2010 | 774 | 0.090 |
Why?
| Microscopy, Confocal | 1 | 2010 | 314 | 0.090 |
Why?
| Risk Factors | 3 | 2018 | 9000 | 0.080 |
Why?
| Amphetamine-Related Disorders | 1 | 2009 | 28 | 0.080 |
Why?
| Suture Techniques | 1 | 2010 | 134 | 0.080 |
Why?
| Ocular Motility Disorders | 1 | 2009 | 27 | 0.080 |
Why?
| Sodium Chloride | 1 | 2009 | 144 | 0.080 |
Why?
| Disease Progression | 2 | 2020 | 2490 | 0.080 |
Why?
| Vasoconstriction | 1 | 2010 | 213 | 0.080 |
Why?
| Choroidal Neovascularization | 1 | 2009 | 44 | 0.080 |
Why?
| Methamphetamine | 1 | 2009 | 51 | 0.080 |
Why?
| Retinal Vein Occlusion | 1 | 2008 | 13 | 0.080 |
Why?
| Immunosuppressive Agents | 1 | 2012 | 681 | 0.080 |
Why?
| Chondroitin | 1 | 2008 | 5 | 0.080 |
Why?
| Microscopy, Fluorescence | 1 | 2010 | 412 | 0.080 |
Why?
| Fluorescein | 1 | 2008 | 27 | 0.080 |
Why?
| Microvilli | 1 | 2008 | 70 | 0.080 |
Why?
| Lymphocyte Count | 1 | 2008 | 136 | 0.080 |
Why?
| Mice | 6 | 2016 | 15520 | 0.080 |
Why?
| Rupture | 1 | 2008 | 105 | 0.080 |
Why?
| Kaplan-Meier Estimate | 1 | 2010 | 842 | 0.080 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 827 | 0.080 |
Why?
| United States | 5 | 2022 | 12555 | 0.080 |
Why?
| Perioperative Care | 2 | 2019 | 132 | 0.080 |
Why?
| Vitamins | 1 | 2009 | 158 | 0.080 |
Why?
| Time Factors | 3 | 2019 | 6412 | 0.080 |
Why?
| Central Nervous System Stimulants | 1 | 2009 | 142 | 0.080 |
Why?
| Neuropsychological Tests | 1 | 2012 | 1032 | 0.080 |
Why?
| Inflammation | 1 | 2018 | 2566 | 0.070 |
Why?
| Cell Line | 1 | 2013 | 2707 | 0.070 |
Why?
| Mice, Inbred BALB C | 3 | 2015 | 1206 | 0.070 |
Why?
| Molteno Implants | 1 | 2006 | 2 | 0.070 |
Why?
| Conjunctivitis | 1 | 2006 | 19 | 0.070 |
Why?
| Uveal Diseases | 1 | 2006 | 5 | 0.070 |
Why?
| Glucosyltransferases | 1 | 2006 | 3 | 0.070 |
Why?
| Lymphocytes | 1 | 2008 | 347 | 0.070 |
Why?
| Sweat Gland Neoplasms | 1 | 2006 | 6 | 0.070 |
Why?
| Scleral Buckling | 1 | 2006 | 18 | 0.070 |
Why?
| Eyelid Neoplasms | 1 | 2006 | 8 | 0.070 |
Why?
| Sutures | 1 | 2006 | 61 | 0.070 |
Why?
| Motorcycles | 1 | 2005 | 7 | 0.070 |
Why?
| Glycosylation | 1 | 2006 | 129 | 0.070 |
Why?
| Prevalence | 1 | 2012 | 2326 | 0.070 |
Why?
| Sleep | 2 | 2023 | 660 | 0.070 |
Why?
| Adenocarcinoma, Mucinous | 1 | 2006 | 59 | 0.070 |
Why?
| Forecasting | 1 | 2007 | 353 | 0.060 |
Why?
| Syndrome | 1 | 2006 | 344 | 0.060 |
Why?
| Predictive Value of Tests | 2 | 2023 | 1868 | 0.060 |
Why?
| Treatment Failure | 1 | 2006 | 341 | 0.060 |
Why?
| Accidents, Traffic | 1 | 2005 | 178 | 0.060 |
Why?
| Vietnam | 1 | 2023 | 22 | 0.060 |
Why?
| Incidence | 1 | 2010 | 2424 | 0.060 |
Why?
| Optical Imaging | 2 | 2015 | 56 | 0.060 |
Why?
| Reoperation | 1 | 2006 | 557 | 0.060 |
Why?
| Materials Testing | 2 | 2015 | 359 | 0.060 |
Why?
| Sex Factors | 1 | 2009 | 1781 | 0.060 |
Why?
| Photography | 1 | 2023 | 93 | 0.060 |
Why?
| Injections, Intraocular | 2 | 2014 | 10 | 0.060 |
Why?
| Clinical Trials as Topic | 1 | 2007 | 969 | 0.050 |
Why?
| Apoptosis | 1 | 2011 | 2484 | 0.050 |
Why?
| Age Factors | 1 | 2009 | 2995 | 0.050 |
Why?
| Prognosis | 2 | 2020 | 3443 | 0.050 |
Why?
| Manometry | 1 | 2021 | 89 | 0.050 |
Why?
| Coronary Angiography | 1 | 2022 | 311 | 0.040 |
Why?
| Membrane Proteins | 1 | 2006 | 1055 | 0.040 |
Why?
| Adolescent | 4 | 2019 | 18480 | 0.040 |
Why?
| Carbonic Anhydrase Inhibitors | 1 | 2018 | 18 | 0.040 |
Why?
| Preoperative Period | 1 | 2019 | 110 | 0.040 |
Why?
| Axial Length, Eye | 1 | 2018 | 9 | 0.040 |
Why?
| Exfoliation Syndrome | 1 | 2018 | 10 | 0.040 |
Why?
| Corneal Pachymetry | 1 | 2018 | 16 | 0.040 |
Why?
| Refraction, Ocular | 1 | 2018 | 31 | 0.040 |
Why?
| Drug Resistance | 1 | 2018 | 167 | 0.040 |
Why?
| Pupil | 1 | 2016 | 13 | 0.040 |
Why?
| Rats | 2 | 2016 | 5392 | 0.040 |
Why?
| Neurites | 1 | 2016 | 45 | 0.040 |
Why?
| Biomimetics | 1 | 2016 | 38 | 0.040 |
Why?
| Nerve Regeneration | 1 | 2016 | 53 | 0.030 |
Why?
| Fluoroquinolones | 1 | 2016 | 42 | 0.030 |
Why?
| Prednisolone | 1 | 2016 | 76 | 0.030 |
Why?
| Color Perception Tests | 1 | 2015 | 3 | 0.030 |
Why?
| Slit Lamp | 1 | 2015 | 2 | 0.030 |
Why?
| Macaca fascicularis | 1 | 2015 | 53 | 0.030 |
Why?
| Medical Device Legislation | 1 | 2015 | 2 | 0.030 |
Why?
| Opossums | 1 | 2015 | 10 | 0.030 |
Why?
| Anterior Eye Segment | 1 | 2015 | 10 | 0.030 |
Why?
| Device Approval | 1 | 2015 | 21 | 0.030 |
Why?
| Muscle, Smooth | 1 | 2016 | 157 | 0.030 |
Why?
| Color | 1 | 2015 | 76 | 0.030 |
Why?
| Mutation | 1 | 2006 | 3457 | 0.030 |
Why?
| Academies and Institutes | 1 | 2015 | 44 | 0.030 |
Why?
| False Positive Reactions | 1 | 2015 | 115 | 0.030 |
Why?
| Device Removal | 1 | 2016 | 127 | 0.030 |
Why?
| Axons | 1 | 2016 | 185 | 0.030 |
Why?
| Validation Studies as Topic | 1 | 2014 | 21 | 0.030 |
Why?
| Membrane Lipids | 1 | 2015 | 88 | 0.030 |
Why?
| Diffusion of Innovation | 1 | 2015 | 98 | 0.030 |
Why?
| Drug Utilization | 1 | 2015 | 169 | 0.030 |
Why?
| Models, Animal | 1 | 2016 | 363 | 0.030 |
Why?
| Quality Control | 1 | 2014 | 159 | 0.030 |
Why?
| Reference Standards | 1 | 2014 | 176 | 0.030 |
Why?
| Drug Evaluation, Preclinical | 1 | 2014 | 180 | 0.030 |
Why?
| Corneal Stroma | 1 | 2013 | 18 | 0.030 |
Why?
| Photoreceptor Cells, Vertebrate | 1 | 2013 | 25 | 0.030 |
Why?
| Histocytochemistry | 1 | 2013 | 82 | 0.030 |
Why?
| Staining and Labeling | 1 | 2013 | 146 | 0.030 |
Why?
| Lipid Metabolism | 1 | 2015 | 477 | 0.030 |
Why?
| Finite Element Analysis | 1 | 2012 | 70 | 0.030 |
Why?
| Biological Availability | 1 | 2012 | 126 | 0.030 |
Why?
| Permeability | 1 | 2012 | 156 | 0.030 |
Why?
| Attitude to Health | 1 | 2015 | 410 | 0.020 |
Why?
| Spectrometry, Fluorescence | 1 | 2012 | 173 | 0.020 |
Why?
| Models, Statistical | 1 | 2015 | 636 | 0.020 |
Why?
| Chronic Disease | 2 | 2008 | 1636 | 0.020 |
Why?
| Drug Compounding | 1 | 2011 | 90 | 0.020 |
Why?
| Massage | 1 | 2011 | 44 | 0.020 |
Why?
| Stress, Mechanical | 1 | 2012 | 443 | 0.020 |
Why?
| Diagnostic Techniques, Endocrine | 1 | 2009 | 14 | 0.020 |
Why?
| Particle Size | 1 | 2011 | 345 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2014 | 1795 | 0.020 |
Why?
| Cohort Studies | 1 | 2019 | 5116 | 0.020 |
Why?
| Pigment Epithelium of Eye | 1 | 2006 | 34 | 0.020 |
Why?
| Ultrasonography | 1 | 2011 | 716 | 0.020 |
Why?
| Anti-Bacterial Agents | 1 | 2016 | 1510 | 0.020 |
Why?
| Mohs Surgery | 1 | 2006 | 25 | 0.020 |
Why?
| Radiotherapy, Adjuvant | 1 | 2006 | 189 | 0.020 |
Why?
| Biomarkers | 1 | 2015 | 3588 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2006 | 736 | 0.020 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2009 | 468 | 0.010 |
Why?
| Biopsy | 1 | 2006 | 1079 | 0.010 |
Why?
| Diagnosis, Differential | 1 | 2006 | 1384 | 0.010 |
Why?
| Pregnancy | 1 | 2009 | 5691 | 0.010 |
Why?
| Infant | 1 | 2010 | 8293 | 0.010 |
Why?
| Child, Preschool | 1 | 2010 | 9491 | 0.010 |
Why?
| Child | 1 | 2010 | 19129 | 0.010 |
Why?
|
|
Kahook's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|